propranolol has been researched along with urapidil in 16 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (31.25) | 18.7374 |
| 1990's | 2 (12.50) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 6 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Johans, C; Kinnunen, PK; Söderlund, T; Suomalainen, P | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Caccia, MR; Cataldi, G; Galimberti, V; Mangoni, A; Osio, M | 1 |
| Flanagan, PH; Galbraith, H; Jackson, SH; Jamieson, MJ; Patel, SS; Shepherd, AM; Stewart, W | 1 |
| Rassier, ME; Shebuski, RJ; Zimmerman, BG | 1 |
| Jurna, I; Sanders, KH | 1 |
| Shebuski, RJ; Zeigler, DW; Zimmerman, BG | 1 |
| Garnier, P; Goudey-Perriere, F; Perriere, C; Sauviat, MP | 1 |
| Albenque, JP; Balanescu, S; Bounhoure, JP; Doazan, JP; Fourcade, J; Galinier, M; Montastruc, JL; Montastruc, P; Rougé, P; Senard, JM | 1 |
2 trial(s) available for propranolol and urapidil
| Article | Year |
|---|---|
Propranolol, clonidine, urapidil and trazodone infusion in essential tremor: a double-blind crossover trial.
Topics: Adult; Aged; Aged, 80 and over; Clonidine; Double-Blind Method; Female; Humans; Injections, Intravenous; Male; Middle Aged; Piperazines; Propranolol; Trazodone; Tremor | 1989 |
The assessment of the beta-blocking activity of urapidil: a new method.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Heart Rate; Humans; Isoproterenol; Male; Piperazines; Propranolol; Random Allocation | 1986 |
14 other study(ies) available for propranolol and urapidil
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Surface activity profiling of drugs applied to the prediction of blood-brain barrier permeability.
Topics: Blood-Brain Barrier; Lipid Bilayers; Micelles; Permeability; Pharmaceutical Preparations; Structure-Activity Relationship; Surface Properties | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics | 2011 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Beta 1-adrenoceptor antagonism by urapidil prior to and after the alpha 2-antagonist rauwolscine in anesthetized dogs.
Topics: Animals; Blood Pressure; Dobutamine; Dogs; Drug Administration Schedule; Electric Stimulation; Female; Heart; Heart Rate; Hexamethonium Compounds; Male; Piperazines; Propranolol; Receptors, Adrenergic, beta; Vagotomy; Yohimbine | 1986 |
Effects of urapidil, clonidine, prazosin and propranolol on autonomic nerve activity, blood pressure and heart rate in anaesthetized rats and cats.
Topics: Anesthesia; Animals; Antihypertensive Agents; Autonomic Nervous System; Blood Pressure; Cats; Clonidine; Female; Heart Rate; Hemodynamics; In Vitro Techniques; Male; Neurons; Piperazines; Prazosin; Propranolol; Quinazolines; Rats; Rats, Inbred Strains; Species Specificity; Splanchnic Nerves; Sympathetic Nervous System; Vagus Nerve | 1985 |
Central and peripheral cardiovascular actions of urapidil in normotensive and Goldblatt hypertensive animals.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Brain; Cats; Cisterna Magna; Dogs; Dose-Response Relationship, Drug; Female; Heart Rate; Hypertension, Renovascular; Injections, Intravenous; Male; Phenylephrine; Piperazines; Pressoreceptors; Propranolol; Reflex | 1984 |
Does crude venom of the stonefish (Synanceia verrucosa) activate beta-adrenoceptors in the frog heart muscle?
Topics: Action Potentials; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Dose-Response Relationship, Drug; Fish Venoms; Fishes; Heart; Heart Atria; Myocardial Contraction; Myocardium; Piperazines; Propranolol; Rana esculenta; Receptors, Adrenergic, beta; Yohimbine | 1995 |
Lack of haemodynamic effects of nitric oxide on post-capillary pulmonary hypertension induced by acute sino-aortic denervation.
Topics: Adrenergic beta-Antagonists; Animals; Denervation; Dogs; Enzyme Inhibitors; Hemodynamics; Hypertension, Pulmonary; Male; Microcirculation; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Piperazines; Propranolol; Pulmonary Circulation; Sinoatrial Node; Vasodilator Agents | 1997 |